Evommune, Inc. EVMN 深 滬
等待開盤 06-25 09:30:00 美东时间
23.56
-0.690
-2.85%
華盛通- 最 高25.52
- 今 開24.14
- 成交量 104.35万股
- 最 低 23.3275
- 昨 收 24.25
- 總市值 8.49亿
- 52周最高 33.20
- 市盈率 靜 --
- 換手率 2.90%
- 52周最低 13.885
- 委 比 99.50%
- 總股本 3601.84万
- 歷史最高 33.20
- 量 比 1.83
- 振 幅 9.04%
- 歷史最低 13.885
- 每 手 1
- 風險率 3.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 市值直指1.8万亿美元？瑞银给出美光1600美元天价目标！华尔街绩前集体上调迈威尔科技目标价
今日重点评级关注：Canaccord Genuity：维持Dakota Gold"投机性买入"评级，目标价从16美元升至18美元；瑞杰金融：上调Tectonic Therapeutic评级至"强烈买入"，目标价从76美元升至81美元
05-27 17:33
HC Wainwright & Co. Reiterates Buy on Evommune, Maintains $50 Price Target
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Evommune (NYSE:EVMN) with a Buy and maintains $50 price target.
05-26 18:53
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
Morgan Stanley Maintains Overweight on Evommune, Raises Price Target to $55
Morgan Stanley analyst Judah Frommer maintains Evommune (NYSE:EVMN) with a Overweight and raises the price target from $54 to $55.
05-12 01:11
Evommune Q1 EPS $(0.64) Beats $(0.71) Estimate
Evommune (NYSE:EVMN) reported quarterly losses of $(0.64) per share which beat the analyst consensus estimate of $(0.71) by 9.86 percent.
05-08 04:38
Evommune Files Prospectus For Resale Of Up To 4,494,279 Shares Of Common Stock By Selling Stockholders
Up to 4,494,279 Shares of Common StockThis prospectus relates to the resale from time to time of up to 4,494,279 shares of common stock, par value $0.0001 per share (the "Shares"), of Evommune, Inc. by the selling
04-18 04:11
美股大行评级 | 大砍54%！大摩下调Robinhood 目标价从147降至95美元；星座品牌酒业(STZ)获8家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从9.5美元升至9.75美元；Citizens：维持戴夫"跑赢大市"评级，目标价从310美元升至335美元
04-13 14:07
RBC Capital Reiterates Outperform on Evommune, Maintains $48 Price Target
RBC Capital analyst Brian Abrahams reiterates Evommune (NYSE:EVMN) with a Outperform and maintains $48 price target.
04-10 22:04
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
Nvidia To Rally Around 79%? Here Are 10 Top Analyst Forecasts For Wednesday
Top analysts changed outlook on top names. Mizuho, Needham, Rothschild & Co, HC Wainwright & Co, Stifel, BTIG, Goldman Sachs made changes.
03-18 20:19
